Lyn regulates GM-CSF signaling [11, 12], a key pathway implicated in myeloproliferative disorders and leukemogenesis by increasing the proliferative capacity of cells and extending their lifespan [26]. This evidence concerns the gene CSF2 and myeloproliferative disorder.